Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

13.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.9K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

7.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

KLaR: fusing knowledge graphs and language models for biomedical target discovery.

Bioinformatics (Oxford, England)·2026
Same author

NABP-BERT: NANOBODY®-antigen binding prediction based on bidirectional encoder representations from transformers (BERT) architecture.

Briefings in bioinformatics·2024
Same author

MSlocPRED: deep transfer learning-based identification of multi-label mRNA subcellular localization.

Briefings in bioinformatics·2024
Same author

Surface-based multimodal protein-ligand binding affinity prediction.

Bioinformatics (Oxford, England)·2024
Same author

MoleMCL: a multi-level contrastive learning framework for molecular pre-training.

Bioinformatics (Oxford, England)·2024
Same author

A general hypergraph learning algorithm for drug multi-task predictions in micro-to-macro biomedical networks.

PLoS computational biology·2023

Related Experiment Video

Updated: Oct 6, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

5

Drug-target interactions prediction via deep collaborative filtering with multiembeddings.

Ruolan Chen1, Feng Xia1, Bing Hu1

  • 1Department of Computer Science and Technology, Xiamen University, Xiamen, China.

Briefings in Bioinformatics
|January 19, 2022
PubMed
Summary

This study introduces DCFME, a deep collaborative filtering model for predicting drug-target interactions (DTIs). DCFME enhances prediction accuracy, especially on sparse data, by integrating multi-feature information and employing focal loss.

Keywords:
collaborative filteringdrug–target interactionsheterogeneous network

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

946
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K

Related Experiment Videos

Last Updated: Oct 6, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

5
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

946
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K

Area of Science:

  • Computational pharmacology
  • Bioinformatics
  • Drug discovery

Background:

  • Drug-target interactions (DTIs) are crucial for modern medicine development.
  • Traditional experimental DTI prediction is time-consuming, costly, and inefficient.
  • Computational methods offer high-throughput DTI prediction.

Purpose of the Study:

  • To develop an advanced computational model for accurate DTI prediction.
  • To address the limitations of existing DTI prediction methods, particularly on sparse datasets.
  • To improve drug discovery efficiency through enhanced DTI prediction.

Main Methods:

  • Developed a deep collaborative filtering prediction model with multiembeddings (DCFME).
  • Utilized two representation learning algorithms to extract heterogeneous network features.
  • Employed focal loss to focus training on challenging sparse and hard samples.

Main Results:

  • DCFME demonstrated significant performance improvements over five baseline methods, especially on sparse datasets.
  • The model showed enhanced robustness and generalization capabilities in difficult prediction scenarios.
  • DCFME effectively integrates multi-feature information for simulating drug-target relationships.

Conclusions:

  • DCFME offers a powerful and efficient approach for DTI prediction.
  • The model's ability to handle sparse data and complex relationships advances computational pharmacology.
  • This method holds promise for accelerating drug discovery and development.